Allianz Asset Management GmbH cut its position in Xylem Inc (NYSE:XYL) by 5.1% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 2,120,361 shares of the industrial products company’s stock after selling 114,229 shares during the quarter. Allianz Asset Management GmbH’s holdings in Xylem were worth $144,609,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Chevy Chase Trust Holdings Inc. boosted its position in Xylem by 0.9% in the third quarter. Chevy Chase Trust Holdings Inc. now owns 197,184 shares of the industrial products company’s stock valued at $12,349,000 after buying an additional 1,670 shares in the last quarter. Highbridge Capital Management LLC acquired a new position in Xylem in the third quarter valued at about $254,000. Patten Group Inc. boosted its position in Xylem by 295.6% in the third quarter. Patten Group Inc. now owns 127,490 shares of the industrial products company’s stock valued at $2,009,000 after buying an additional 95,259 shares in the last quarter. Bank of Montreal Can boosted its position in Xylem by 4.0% in the fourth quarter. Bank of Montreal Can now owns 762,194 shares of the industrial products company’s stock valued at $51,981,000 after buying an additional 29,552 shares in the last quarter. Finally, Swiss National Bank boosted its position in Xylem by 1.2% in the third quarter. Swiss National Bank now owns 661,922 shares of the industrial products company’s stock valued at $41,456,000 after buying an additional 8,100 shares in the last quarter. Hedge funds and other institutional investors own 85.14% of the company’s stock.
Xylem Inc (NYSE:XYL) opened at $75.75 on Wednesday. Xylem Inc has a 12-month low of $47.37 and a 12-month high of $76.81. The stock has a market cap of $13,600.00, a P/E ratio of 36.42, a PEG ratio of 1.45 and a beta of 1.20. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.41 and a current ratio of 1.88.
The business also recently announced a quarterly dividend, which will be paid on Thursday, March 15th. Stockholders of record on Thursday, February 15th will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.11%. This is a positive change from Xylem’s previous quarterly dividend of $0.18. The ex-dividend date of this dividend is Wednesday, February 14th. Xylem’s dividend payout ratio is presently 40.38%.
A number of equities analysts have commented on the stock. Zacks Investment Research lowered shares of Xylem from a “buy” rating to a “hold” rating in a research report on Tuesday, February 13th. BMO Capital Markets restated a “buy” rating and issued a $86.00 price target on shares of Xylem in a research report on Friday, February 2nd. Seaport Global Securities restated a “buy” rating on shares of Xylem in a research report on Wednesday, November 1st. Canaccord Genuity restated a “hold” rating and issued a $75.00 price target on shares of Xylem in a research report on Sunday, January 28th. Finally, Oppenheimer restated a “buy” rating on shares of Xylem in a research report on Tuesday, October 31st. Six analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $70.08.
In other news, insider Tomas Brannemo sold 2,260 shares of the company’s stock in a transaction that occurred on Tuesday, December 19th. The shares were sold at an average price of $67.75, for a total transaction of $153,115.00. Following the transaction, the insider now directly owns 10,975 shares in the company, valued at $743,556.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Steven R. Loranger sold 17,139 shares of the company’s stock in a transaction that occurred on Wednesday, December 20th. The stock was sold at an average price of $68.10, for a total transaction of $1,167,165.90. Following the transaction, the director now owns 26,150 shares in the company, valued at $1,780,815. The disclosure for this sale can be found here. Insiders have sold 76,896 shares of company stock worth $5,276,812 over the last quarter. 0.75% of the stock is owned by company insiders.
COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3227148/allianz-asset-management-gmbh-has-144-61-million-position-in-xylem-inc-xyl.html.
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.